Raras
Buscar doenças, sintomas, genes...
Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual
ORPHA:2379CID-10 · G20CID-11 · LD90.1OMIM 311510DOENÇA RARA

É uma condição que afeta os gânglios da base, uma parte do cérebro importante para controlar os movimentos. Ela se manifesta com sintomas parecidos aos do Parkinson, como: mudanças na postura, tremores e rigidez (dificuldade de movimentação). Outras características incluem um cérebro maior que o normal (megalencefalia) e um atraso intelectual que pode variar de pessoa para pessoa. Podem-se observar também testa saliente, reflexos cerebrais que deveriam sumir na infância mas persistem, estrabismo (olhos vesgos) e convulsões. A condição foi identificada em três gerações de uma mesma família e é transmitida de forma ligada ao cromossomo X. O gene responsável por ela está localizado em uma região específica desse cromossomo, a Xq27.3-qter.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma condição que afeta os gânglios da base, uma parte do cérebro importante para controlar os movimentos. Ela se manifesta com sintomas parecidos aos do Parkinson, como: mudanças na postura, tremores e rigidez (dificuldade de movimentação). Outras características incluem um cérebro maior que o normal (megalencefalia) e um atraso intelectual que pode variar de pessoa para pessoa. Podem-se observar também testa saliente, reflexos cerebrais que deveriam sumir na infância mas persistem, estrabismo (olhos vesgos) e convulsões. A condição foi identificada em três gerações de uma mesma família e é transmitida de forma ligada ao cromossomo X. O gene responsável por ela está localizado em uma região específica desse cromossomo, a Xq27.3-qter.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
2
pacientes catalogados
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PE, CE, DF, SP +5CID-10: G20
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
8 sintomas
👁️
Olhos
1 sintomas
🧬
Pele e cabelo
1 sintomas

+ 16 sintomas em outras categorias

Características mais comuns

100%prev.
Rigidez
Muito frequente (99-80%)
100%prev.
Bradicinesia
Frequência: 7/7
100%prev.
Parkinsonismo
Frequência: 7/7
100%prev.
Parkinsonismo com resposta favorável à medicação dopaminérgica
Frequência: 6/6
90%prev.
Deficiência intelectual
Muito frequente (99-80%)
90%prev.
Macrocefalia
Muito frequente (99-80%)
26sintomas
Muito frequente (11)
Frequente (4)
Ocasional (3)
Sem dados (8)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 26 características clínicas mais associadas, ordenadas por frequência.

RigidezRigidity
Muito frequente (99-80%)100%
BradicinesiaBradykinesia
Frequência: 7/7100%
ParkinsonismoParkinsonism
Frequência: 7/7100%
Parkinsonismo com resposta favorável à medicação dopaminérgicaParkinsonism with favorable response to dopaminergic medication
Frequência: 6/6100%
Deficiência intelectualIntellectual disability
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202470 papers
Linha do tempo
2026Hoje · 2026📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

RAB39BRas-related protein Rab-39BDisease-causing germline mutation(s) (loss of function) inDesconhecido
FUNÇÃO

The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:27103069). RAB39B is involved in autophagy and may function in autophagosome formation (PubMed:27103069, PubMed:3

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicle membraneGolgi apparatusCytoplasmic vesicle, autophagosome membraneAutolysosome membrane

VIAS BIOLÓGICAS (1)
RAB geranylgeranylation
MECANISMO DE DOENÇA

Intellectual developmental disorder, X-linked 72

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked forms, while syndromic forms present with associated physical, neurological and/or psychiatric manifestations. XLID72 patients can manifest autism spectrum disorder, seizures and macrocephaly as additional features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
22.7 TPM
Cerebelo
15.8 TPM
Brain Frontal Cortex BA9
15.2 TPM
Pituitária
13.2 TPM
Brain Spinal cord cervical c-1
10.8 TPM
OUTRAS DOENÇAS (3)
early-onset parkinsonism-intellectual disability syndromeintellectual disability, X-linked 72non-syndromic X-linked intellectual disability
HGNC:16499UniProt:Q96DA2

Variantes genéticas (ClinVar)

266 variantes patogênicas registradas no ClinVar.

🧬 RAB39B: GRCh38/hg38 Xq28(chrX:154881139-155396181)x2 ()
🧬 RAB39B: GRCh38/hg38 Xq26.3-28(chrX:137491159-155700385)x2 ()
🧬 RAB39B: NM_171998.4(RAB39B):c.421C>G (p.Leu141Val) ()
🧬 RAB39B: GRCh37/hg19 Xq23-28(chrX:113417246-155233731)x1 ()
🧬 RAB39B: GRCh37/hg19 Xq28(chrX:150351569-155233731)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 8 variantes classificadas pelo ClinVar.

5
3
Patogênica (62.5%)
VUS (37.5%)
VARIANTES MAIS SIGNIFICATIVAS
LOC130068896: NC_000023.11:g.155264167_155265545del [Pathogenic]
RAB39B: NM_171998.4(RAB39B):c.215+3G>A [Conflicting classifications of pathogenicity]
RAB39B: NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg) [Pathogenic]
CLIC2: NC_000023.11:g.(155246216_?)_(?_155288781)del [Pathogenic]
RAB39B: NM_171998.4(RAB39B):c.503C>A (p.Thr168Lys) [Pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual

Centros para Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
0 papers (10 anos)
#1

At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson's disease.

BMJ neurology open2026

Dopamine dysregulation syndrome (DDS) is an uncommon but debilitating complication of Parkinson's disease (PD), characterised by a compulsive overuse of dopaminergic therapy. Most reported cases are male and involve daily oral levodopa (L-DOPA) intake between 2000 and 4000 mg. We describe a female with young-onset PD who progressively escalated oral L-DOPA intake to a peak of 10 000 mg/day prior to subthalamic nucleus deep brain stimulation (DBS). A structured psychiatric assessment was performed after DBS. Whole-exome sequencing was conducted to evaluate possible genetic susceptibility. The patient developed compulsive medication use, impulse control disorders and gingival black pigmentation with near-total tooth loss. Classical hedonistic DDS features were absent. Following DBS, the L-DOPA dose stabilised at 1800 mg/day, but psychosis emerged, requiring hospitalisation. Genetic testing did not identify a pathogenic cause for early-onset PD; a rare missense variant of uncertain significance was detected without established clinical relevance. This case represents the highest sustained oral L-DOPA dose reported in PD. Despite lacking several core DDS features, the pattern of compulsive use suggests dopaminergic dysregulation. This case highlights limitations in current DDS criteria and suggests that contextual features, such as motor disability, psychological reinforcement and individual vulnerability, should be integrated into future refinements.

#2

Association of Bassoon (BSN) Gene Mutations With Gait and Motor Impairments in Parkinson's Disease.

The European journal of neuroscience2026 Mar

Parkinson's disease (PD) is a neurodegenerative syndrome with diverse biological drivers, where gait and balance dysfunction remain among the most disabling and least understood symptoms. Bassoon (BSN), a presynaptic active-zone organizer, has been implicated in various parkinsonian disorders. Here, we report the impact of BSN mutations on motor symptoms, especially gait-related symptoms, in PD patients. Our study included 110 patients carrying BSN mutations in a cohort of 668 South Asian early-onset PD (age of onset < 50 years). Clinical motor features were compared between variant carriers and noncarriers. Computational tools (CADD, PolyPhen-2, I-Mutant2.0 and ConSurf) predicted deleteriousness of individual mutations, whereas GeneMANIA and STRING speculated Bassoon's functional interactions. Subjects carrying BSN variants exhibited significantly increased burden of motor-related symptoms (p = 0.036). Freezing of gait (FOG) and shuffling gait (SG) were significantly more prevalent in BSN mutation carriers (p = 0.03). Presence of BSN mutation correlated with an increased disease stage, an effect driven by FOG and SG (p = 0.012). Rare BSN mutations (MAF < 0.1%) clustered in the Bassoon C-terminal region (aa 3500-3800), at a threefold frequency than expected (p < 0.01), implying a hotspot. In silico analysis identified seven likely pathogenic variants (P171L, A852T, P988A, R1015H, R2561H, R3400W and L3561P). Predictive analyses implicated BSN in axonal transport, presynaptic proteostasis and neurotransmitter release in dopaminergic/cholinergic neurons. Our findings put forth BSN mutations as a potential genetic risk factor for PD-related motor and gait dysfunction, warranting further research in this respect.

#3

Developmental and Epileptic Encephalopathy due to Cyclin-Dependent Kinase-Like 5 Deficiency: A Single-Center Experience Across Sex Differences.

Pediatric neurology2026 Apr

The cyclin-dependent kinase-like 5 deficiency disorder (CDD) is an ultrarare X-linked disorder causing early-onset epileptic encephalopathy and severe developmental deficits. Few studies exist on its electroclinical features, outcomes, sex differences, and neuroimaging, particularly from India. This study aims to describe the electroclinical syndrome, developmental profile, radiological findings, and outcomes in patients with CDD and to compare these factors between males and females. This is a hospital-based observational study of patients diagnosed with CDD identified from a prospectively maintained registry of children with developmental and epileptic encephalopathy. Data on demographics, seizure types, epilepsy syndromes, antiseizure medications, electroencephalography findings, developmental assessments, genetic characteristics, brain magnetic resonance imaging, and outcomes were collected. We included 12 patients with pathogenic (9) and likely pathogenic (3) variants in cyclin-dependent kinase-like 5 (CDKL5), among whom seven were female. The mean age at onset of seizures was 5.95 ± 5.56 months and was higher for males than females (8.6 ± 7.23 vs 3.19 ± 2.47). The most common seizure types at onset were tonic seizures in 6 (50%) children and epileptic spasms in 4 (33.3%). Lennox-Gastaut syndrome and West syndrome were the most frequent epilepsy syndromes. The median number of seizures per person was 2.9, and the median number of antiseizure medications used was 6 during their lifetime. Magnetic resonance imaging revealed cerebral volume loss in 7 children and white matter lesions in 6. Severe developmental deficits, a Rett-like phenotype, and cortical visual impairment were observed in three-fourths of the children, and regression of milestones occurred in two-thirds. Repetitive motor behavior (P 0.0455) and regression (P 0.0101) were more common in females. CDD causes refractory epilepsy and severe developmental deficits irrespective of the sex of the patient, variant type, and treatment.

#4

Bardet-Biedl syndrome presenting with early-onset infantile obesity.

BMJ case reports2026 Jan 29

Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive genetic disorder. Polydactyly, obesity, pigmentary retinal degeneration, intellectual disability, kidney abnormalities and hypogonadism are common features. We report an infant who presented with obesity, micropenis, polydactyly and syndromic features, raising suspicion of a genetic syndrome. Infantile obesity is among the most common clinical findings in BBS. Whole-exome sequencing confirmed a mutation in the BBS4 gene which was homozygous and associated with BBS. The child was discharged in stable condition after 11 days of hospitalisation. On follow-up after 2 years of age, setmelanotide is planned to be initiated for his weight management. Infantile obesity, a rare and early manifestation, played a pivotal role in suspecting syndromic obesity, leading to targeted genetic investigations. The case highlights the importance of recognising early-onset obesity as a diagnostic clue for genetic syndromes by performing next-generation sequencing critical to make firm diagnosis of BBS.

#5

Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmia.

Human molecular genetics2026 Feb 10

Calmodulin is an intracellular Ca2+ sensor that regulates numerous cellular processes through binding effector proteins and changing their activity. Humans have three calmodulin paralogs, CALM1, CALM2 and CALM3, encoding identical proteins, and missense variants in all three are included in the ACMG recommendations for reporting of secondary findings related to early onset sudden cardiac death caused by arrhythmias long QT syndrome and CPVT. Recently, a subset of individuals with de novo variants in calmodulin genes were described who also presented with neurologic phenotypes. Here we report two individuals with the same de novo variant c.419A > T in CALM1 or CALM2 that may generate a 5' splice donor gain and/or a missense change p.E140V. These individuals share hypotonia, motor delay, intellectual disability, and abnormal electroencephalograms but lack cardiac arrhythmia/electrocardiogram abnormalities of previously described CALM-associated disease, suggesting the variant causes phenotypic expansion beyond the known Mendelian phenotypes. RNA-seq of the CALM1 proband blood's sample revealed that most transcripts from the variant allele showed usage of the new splice site or intron retention, without NMD, resulting in frameshifted C-terminal truncations, while a minority resulted in production of the p.E140V missense protein. We modeled the CALM1/2 p.E140V variant as well as a known arrhythmia variant, CALM1 p.E141G, using the C. elegans ortholog cmd-1. We found that cmd-1 E140V displayed both qualitative and quantitative differences in phenotype from E141G, indicating distinct genetic mechanisms. Together, these findings support CALM1/2 phenotypic expansion, with c.419A > T p.E140V resulting in neurologic, but not arrhythmia phenotypes.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson's disease.

BMJ neurology open
2026

Association of Bassoon (BSN) Gene Mutations With Gait and Motor Impairments in Parkinson's Disease.

The European journal of neuroscience
2026

Maternal Child-Directed Speech Toward Children With Infantile Spasm or West Syndrome.

International journal of language &amp; communication disorders
2026

Novel Mutations in KCNJ10 Gene Associated With SeSAME Syndrome: Rare Disorder With Possible Common Mutation.

Molecular genetics &amp; genomic medicine
2026

Early-onset parkinsonism with intellectual disability in an Italian family associated with a PTRHD1 variant.

Parkinsonism &amp; related disorders
2026

Surveying immune and inflammatory alterations in periodontitis among individuals with Down syndrome: A preliminary cross-sectional study.

Journal of periodontology
2026

Expanding the clinical and immunological phenotypes of COPB1 deficiency.

Frontiers in immunology
2026

Developmental and Epileptic Encephalopathy due to Cyclin-Dependent Kinase-Like 5 Deficiency: A Single-Center Experience Across Sex Differences.

Pediatric neurology
2026

Bardet-Biedl syndrome presenting with early-onset infantile obesity.

BMJ case reports
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2026

The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome.

Alzheimer's &amp; dementia (Amsterdam, Netherlands)
2026

Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmia.

Human molecular genetics
2025

A Case Report of PLXNA1-Related Dworschak-Punetha Neurodevelopmental Disorder With Pachygyria and Polymicrogyria.

American journal of medical genetics. Part A
2026

Biallelic FOXRED1 mutations cause infantile mitochondrial encephalopathy with complex I disassembly and basal ganglia degeneration.

Mitochondrion
2025

Biogenesis and function of circular RNAs and their implications in the Down syndrome brain.

Frontiers in genetics
2025

Late onset Lennox-Gastaut syndrome.

Seminars in pediatric neurology
2025

Development and initial validation of the Communication Inventory Disability - Observer Reported (CID-OR): a measure of communication in CDKL5 deficiency disorder.

Journal of patient-reported outcomes
2025

Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.

Frontiers in genetics
2025

Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review.

Journal of clinical medicine
2025

VPS13D-Related Disorders: Description of New Variant and Phenotypic Spectrum Based on Age of Onset.

Cerebellum (London, England)
2025

[Epileptic encephalopathy associated with a mutation in the KCNT1 gene].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2025

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

Imaging and plasma biomarkers for pathological accumulation in Down syndrome.

Brain : a journal of neurology
2025

KCNT1 (Slack/Slo2.2) and KCNT2 (Slick/Slo2.1) Dysregulation in Intellectual Disability and Behavioral Phenotypes: A Systematic Review.

Cureus
2025

Linking Genotype to Clinical Features in SMC1A-Related Phenotypes: From Cornelia de Lange Syndrome to Developmental and Epileptic Encephalopathy, a Comprehensive Review.

Genes
2025

A New Variant in the NALCN Channel Is Responsible for Cerebellar Ataxia and Cognitive Impairment.

Genes
2026

Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

Epilepsia
2026

Dravet syndrome diagnosed in adults.

Practical neurology
2026

Genetic complexity in pediatric onset epilepsy-movement disorder syndromes: Insights from a cohort of 97 subjects.

Epilepsia
2025

Apathy and cognitive decline as the first presentation of SLE-associated vascular dementia: a case report.

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater
2025

Genotype-Phenotype Correlation and Psychiatric Manifestations in a Case of Phelan-McDermid Syndrome With 22q13.33 Deletion.

Cureus
2026

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies.

Annals of clinical and translational neurology
2025

The Emerging Epidemic of Early-Onset Cancer: Global Patterns, Biological Complexity, and Urgent Calls for Action.

Cancer control : journal of the Moffitt Cancer Center
2025

Diagnostic Challenges in Fahr's Disease: A Rare Case of Extensive Basal Ganglia Calcifications.

Cureus
2025

Kohlschütter-Tönz Syndrome: A Rare Clinical Entity with Amelogenesis Imperfecta in Two Siblings, Dental Management and Scoping Review.

Turkish archives of pediatrics
2025

Longitudinal analysis of age-dependent phenotypes in hemizygous male and heterozygous female Cdkl5 mutant mice.

Experimental neurology
2025

Case Report: Observation of early-onset high myopia with fundus tessellation changes in Coffin-Siris syndrome 9 (CSS9) and literature review.

Frontiers in pediatrics
2025

Development of disease-specific growth charts for Argentine Prader-Willi syndrome without growth hormone treatment.

Annals of human biology
2025

FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations.

Genes
2025

Challenges in the management of epilepsy associated with posterior gliosis secondary to perinatal brain injury.

Epilepsy &amp; behavior : E&amp;B
2026

CDKL5 regulates the initiation of retrograde axonal transport through CLIP170-dynactin complex formation.

The FEBS journal
2026

Clinical insights into dental care for siblings with Jamuar syndrome: a rare genetic dual case report.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
2025

Mapping the global burden of early-onset Parkinson's disease: socioeconomic and regional inequalities from the Global Burden of Disease Study 2021.

Frontiers in public health
2025

Telomere Biology, Erosion, and Age-Related Conditions: Insights from Down Syndrome and Other Telomere-Associated Disorders.

Molecular neurobiology
2025

TUBA1A-related tubulinopathy associated with the infantile epileptic spasms syndrome and atypical absence seizures.

Epileptic disorders : international epilepsy journal with videotape
2025

AFG2A-related encephalopathy: Effectiveness of ketogenic diet in epilepsy and mitochondrial dynamics modulation.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

Neuroendocrinology and the Genetics of Obesity.

Endocrinology
2025

A rare case of Dyke-Davidoff-Masson syndrome with concurrent metabolic syndrome.

Radiology case reports
2025

VPS16-Associated Dystonia: A Cohort-Based Clinical, Imaging and Genetic Profile.

Tremor and other hyperkinetic movements (New York, N.Y.)
2025

Unraveling the Genomic Architecture of Supernumerary (Iso-)Dicentric Chromosomes in Dup15q Syndrome: Insight From a Systematic Literature-Based Study.

American journal of medical genetics. Part A
2025

Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex.

bioRxiv : the preprint server for biology
2025

A novel TIMM8A mutation in Mohr-Tranebjaerg syndrome without hearing loss and with basal ganglia iron deposition.

Orphanet journal of rare diseases
2025

Epilepsy phenotype and developmental outcome in girls with mosaicism in X-linked neurodevelopmental disorders.

Epileptic disorders : international epilepsy journal with videotape
2025

Early-Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B.

Movement disorders : official journal of the Movement Disorder Society
2026

The genetic and phenotypic spectrum of GABRB1-related disorders.

Brain : a journal of neurology
2025

Oxidative stress characterizes the dysfunction of thermogenic adipose tissue in a mouse model of down syndrome.

Free radical biology &amp; medicine
2025

Impact of Genetic Testing Using Gene Panels, Exomes, and Genome Sequencing in Romanian Children with Epilepsy.

International journal of molecular sciences
2025

Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions.

Epilepsy &amp; behavior : E&amp;B
2025

French protocol for diagnosis and management of type 1 interferonopathies.

La Revue de medecine interne
2025

Novel biallelic NUP107 variants affect the nuclear pore complex and expand the clinical spectrum to include brain malformations.

Journal of medical genetics
2025

Pathogenic PPP2R5D variants disrupt neuronal development and neurite outgrowth in patient-derived neurons that are reversed by allele-specific knockdown.

HGG advances
2025

STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research.

Biotech (Basel (Switzerland))
2024

SLC2A1 variants cause late-onset epilepsy and the genetic-dependent stage feature : For the China Epilepsy Gene 1.0 Project.

Acta epileptologica
2025

The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment.

Orphanet journal of rare diseases
2025

Gaze behavior in infancy associates with developmental outcome at the age of two years in early-onset epilepsies.

Epilepsy &amp; behavior : E&amp;B
2025

Natural history of patients with autosomal dominant WFS1 pathogenic variants associated with sensorineural hearing loss and optic atrophy.

medRxiv : the preprint server for health sciences
2025

Prevalence and Clinical Characteristics of OTOGL-Associated Hearing Loss Identified in a Cohort of 7065 Japanese Patients with Hearing Loss.

Genes
2025

The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: New mechanism-based therapeutic options.

Epilepsia
2025

Daily life situations and participation of siblings of children with childhood-onset disabilities: a scoping review.

BMJ paediatrics open
2025

Expanding the phenotypic spectrum of DNM1-related disorders: novel GTPase domain variants and their diverse neurological outcomes.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21.

BBA advances
2025

[Access to and Transitions within the Medical Care Process of Persons with Down Syndrome and Dementia: A Qualitative Analysis].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
2024

Engineered tRNAs efficiently suppress CDKL5 premature termination codons.

Scientific reports
2024

Impact of genetic test interpretation on a VPS13B missense variant in Cohen syndrome.

Frontiers in neuroscience
2025

RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations.

Clinical genetics
2025

Recent advances in CYFIP2-associated neurodevelopmental disorders: From human genetics to molecular mechanisms and mouse models.

Brain &amp; development
2024

On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective.

Brain sciences
2024

p75NTR Modulation Reduces Oxidative Stress and the Expression of Pro-Inflammatory Mediators in a Cell Model of Rett Syndrome.

Biomedicines
2025

WDR45-related encephalopathy mimicking Leigh syndrome associated with complex I deficiency: a case report.

European journal of human genetics : EJHG
2025

Developmental and Epileptic Encephalopathies: Need for Bridging the Gaps Between Clinical Syndromes and Underlying Genetic Etiologies.

Indian journal of pediatrics
2024

17q12 microdeletion syndrome.

BMJ case reports
2024

The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome.

EBioMedicine
2025

New Insights Into TRMT10A Syndrome: Case Report and Literature Review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Cohen syndrome: Can early-onset recurrent infections and hypotonia provide early diagnosis and intervention for intellectual disability?

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2024

Novel Splice Site Pathogenic Variant in STXBP1 Gene in a Child with Intellectual Disability, Epilepsy, and Autism Spectrum Disorder: A Case Report.

Molecular syndromology
2024

Sec23IP recruits VPS13B/COH1 to ER exit site-Golgi interface for tubular ERGIC formation.

The Journal of cell biology
2025

Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation.

The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
2024

Demographic Profile and Clinical Characteristics of Adults with Down Syndrome in North-Eastern Romania.

Clinics and practice
2025

Further Delineation of the Proximal 16p11.2 Microdeletion Syndrome: Novel Findings Among 22 New Individuals.

American journal of medical genetics. Part A
2024

Discovery of a TRMT10A mutation in a case of atypical diabetes: Case report.

Diabetes &amp; metabolism
2024

Autistic-relevant behavioral phenotypes of a mouse model of cyclin-dependent kinase-like 5 deficiency disorder.

Autism research : official journal of the International Society for Autism Research
2024

Next-generation sequencing in pediatric-onset epilepsies: Analysis with target panels and personalized therapeutic approach.

Epilepsia open
2024

Network Pharmacology Identifies Intersection Genes of Apigenin and Naringenin in Down Syndrome as Potential Therapeutic Targets.

Pharmaceuticals (Basel, Switzerland)
2025

Dravet-like syndrome with PCDH19 mutations in Taiwan - A multicenter study.

Pediatrics and neonatology
2024

Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.

Multiple sclerosis and related disorders
2024

Clinical features of a novel compound heterozygous genotype of the BBS2 gene: a case report.

The Journal of international medical research
2024

Inherited PURA Pathogenic Variant Associated With a Mild Neurodevelopmental Disorder.

Neurology. Genetics
2024

Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease.

International journal of molecular sciences
2024

WONOEP appraisal: Modeling early onset epilepsies.

Epilepsia
2024

A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency.

Frontiers in immunology
2024

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder.

Molecular therapy : the journal of the American Society of Gene Therapy
2024

Chromosomal instability in a patient with ring chromosome 14 syndrome: a case report.

Molecular cytogenetics
2024

Human HPSE2 gene transfer ameliorates bladder pathophysiology in a mutant mouse model of urofacial syndrome.

eLife
2024

The diagnostic and prognostic role of cerebrospinal fluid biomarkers in glucose transporter 1 deficiency: a systematic review.

European journal of pediatrics
2024

Broadening the scope of multigene panel analysis for adult epilepsy patients.

Epilepsia open
2024

Radiographic and Tomographic Study of the Cranial Bones in Children with the Idiopathic Type of West Syndrome.

Pediatric reports
2024

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder.

Molecular autism
2024

Caudal regression in fetus with de novo SMARCA2 pathogenic variant.

Prenatal diagnosis
2024

Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.

Acta neuropathologica communications
2024

PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response.

American journal of human genetics
2024

Epilepsy phenotypes across the different age-ranges in IQSEC2-related encephalopathy: An Italian multicentre retrospective cohort study.

Seizure
2024

Clinical and genetic analyses of APMR4 syndrome caused by novel biallelic LSS variants.

Frontiers in neuroscience
2024

Establishment of a Biorepository for Down Syndrome: Experience of the Inter-Institutional Multidisciplinary BioBank - BioBIM.

Discovery medicine
2024

Klinefelter Syndrome: A Genetic Disorder Leading to Neuroendocrine Modifications and Psychopathological Vulnerabilities in Children-A Literature Review and Case Report.

Children (Basel, Switzerland)
2024

De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.

BMC medical genomics
2024

Mosaicism-independent mechanisms contribute to Pcdh19-related epilepsy and repetitive behaviors in Xenopus.

Proceedings of the National Academy of Sciences of the United States of America
2024

ITPR1: The missing gene in miosis-ataxia syndrome?

American journal of medical genetics. Part A
2024

Identification of Novel NSD1 variations in four Pediatric cases with sotos Syndrome.

BMC medical genomics
2024

Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review.

Pharmaceuticals (Basel, Switzerland)
2024

A Rare De Novo Mutation in the TRIM8 Gene in a 17-Year-Old Boy with Steroid-Resistant Nephrotic Syndrome: Case Report.

International journal of molecular sciences
2024

Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock-in mice.

The European journal of neuroscience
2024

Myoclonus-Dystonia Plus Syndrome With Early-Onset Multiple Cerebral Cavernous Malformation Type 1 and Growth Hormone Deficiency Associated With Novel 7q21.13-q21.3 Deletion: A Pediatric Case Report.

Cureus
2024

Rebound activation of 5-HT neurons following SSRI discontinuation.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2024

Gut microbiota profile in CDKL5 deficiency disorder patients.

Scientific reports
2024

Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency (SLC6A8).

Neurology
2024

Early-onset West syndrome with developmental delay associated with a novel KLHL20 variant.

American journal of medical genetics. Part A
2024

Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

Epilepsia open
2024

Simpson-Golabi-Behmel syndrome type 1 with normal birth parameters.

BMJ case reports
2024

Type 1 early infantile epileptic encephalopathy: A case report and literature review.

Molecular genetics &amp; genomic medicine
2024

Hyperphagia and impulsivity: use of self-administered Dykens' and in-house impulsivity questionnaires to characterize eating behaviors in children with severe and early-onset obesity.

Orphanet journal of rare diseases
2024

Low-grade parental gonosomal mosaicism in CHD2 siblings with Smith-Magenis-like syndrome.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Early-onset obsessive-compulsive disorder: Sociodemographic and clinical characterization of a large outpatient cohort.

Journal of psychiatric research
2024

Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.

Molecular therapy : the journal of the American Society of Gene Therapy
2024

Down Syndrome Biobank Consortium: A perspective.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2024

Morphometric network-based abnormalities correlate with psychiatric comorbidities and gene expression in PCDH19-related developmental and epileptic encephalopathy.

Translational psychiatry
2024

Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment.

American journal of obstetrics and gynecology
2024

A Novel Heterozygous De Novo MORC2 Missense Variant Causes an Early Onset and Severe Neurodevelopmental Disorder.

Case reports in genetics
2023

Arrhythmias including atrial fibrillation and congenital heart disease in Kleefstra syndrome: a possible epigenetic link.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2024

[Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations].

Acta medica portuguesa
2024

Generation of three induced pluripotent stem cell lines from individuals with Aicardi-Goutières syndrome caused by a c.3019G>A (p.G1007R) autosomal dominant pathogenic variant in ADAR1.

Stem cell research
2024

The Rogdi knockout mouse is a model for Kohlschütter-Tönz syndrome.

Scientific reports
2024

Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.

Epilepsia open
2024

Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep.

Molecular genetics &amp; genomic medicine
2023

c.4168G>A(p.Ala 1390Thr) Variation in KMT2D Gene Detected in an Ultra-treatment-resistant Schizophrenia Patient: A Case Report and Literature Review.

Noro psikiyatri arsivi
2023

Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.

Brain : a journal of neurology
2024

Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B.

Molecular genetics &amp; genomic medicine
2023

A diagnostic conundrum in Bardet-Biedl syndrome: when genetic diagnosis precedes clinical diagnosis.

Endocrinology, diabetes &amp; metabolism case reports
2023

Generation of an induced pluripotent stem cell (iPSC) line SDQLCHi056-A from a patient with Nicolaides-Baraitser syndrome carrying a mutation in SMARCA2 gene.

Stem cell research
2024

Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.

Brain : a journal of neurology
2024

Back pain and disability according to early onset scoliosis etiology in children younger than 10 years.

Spine deformity
2025

Cognitive Function in Early Onset Type 1 Diabetes in Children.

Indian journal of pediatrics
2023

A Novel Neuroimaging Phenotype in the X-Linked Intellectual Disability with a Missense Mutation of CNKSR2 Gene.

Neurology India
2023

VAMP2 Gene-Related Neurodevelopmental Disorder: A Differential Diagnosis for Rett/Angelman-Type Spectrum of Disorders.

Molecular syndromology
2023

Rare predicted loss of function alleles in Bassoon (BSN) are associated with obesity.

NPJ genomic medicine
2024

Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2023

Early-onset catatonia associated with SHANK3 mutations: looking at the autism spectrum through the prism of psychomotor phenomena.

Frontiers in psychiatry
2023

Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.

Multiple sclerosis and related disorders
2023

Electroclinical Features of Epilepsy in Kleefstra Syndrome.

Neuropediatrics
2023

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.

Biomolecules
2024

Characterizing the emergence of amyloid and tau burden in Down syndrome.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2023

Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome).

Revue neurologique
2023

A case of early-onset Parkinson's disease in a patient with KBG syndrome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Mutation in the β-tubulin gene TUBB4A results in epileptic encephalopathy associated with hypomyelinated leucodystrophy: Unexpected findings reveal genetic mosaicism.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2023

Meticulous and Early Understanding of Congenital Cranial Defects Can Save Lives.

Children (Basel, Switzerland)
2023

Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr682-phosphorylated APP βCTF.

Science advances
2023

Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.

Journal of Alzheimer's disease : JAD
2023

Early onset critically ill infants with Schaaf-Yang syndrome: a retrospective study from the China neonatal genomes project and literature review.

Annals of translational medicine
2023

Juvenile Dermatomyositis and Infantile Cerebral Palsy: Aicardi-Gouteres Syndrome, Type 5, with a Novel Mutation in SAMHD1-A Case Report.

Biomedicines
2023

A rare early-onset neonatal case of Birk-Barel syndrome presenting severe obstructive sleep apnea: a case report.

Frontiers in medicine
2023

From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome.

Frontiers in genetics
2023

Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report.

Brain &amp; development
2023

Histological Analysis of a Mouse Model of the 22q11.2 Microdeletion Syndrome.

Biomolecules
2023

Deep phenotypic characterization of the retinal dystrophy in patients with RNU4ATAC-associated Roifman syndrome.

Eye (London, England)
2023

ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks.

Human molecular genetics
2023

Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder.

Neurobiology of disease
2023

De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia.

BMC medical genomics
2023

Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature.

Frontiers in pediatrics
2023

Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.

Acta neuropathologica
2023

Consensus recommendations on sleeping problems in Phelan-McDermid syndrome.

European journal of medical genetics
2024

MED12 variants associated with X-linked recessive partial epilepsy without intellectual disability.

Seizure
2023

Whole-exome sequencing revealed a novel homozygous missense variant in OSGEP gene: a case report of Galloway-Mowat syndrome in Iran.

CEN case reports
2023

Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism.

International journal of molecular sciences
2022

Epilepsy or neurodevelopmental disorders are associated with homozygous and pathogenic ELP2 variation in three siblings.

Neurocase
2023

Cohen syndrome and early-onset epileptic encephalopathy in male triplets: two disease-causing mutations in VPS13B and NAPB.

Neurogenetics
2022

Reviewed and updated Algorithm for Genetic Characterization of Syndromic Obesity Phenotypes.

Current genomics
2023

The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders.

Brain : a journal of neurology
2023

Natural history of MRAS-related Noonan syndrome: Evidence of mild adult-onset left ventricular hypertrophy and neuropsychiatric features.

American journal of medical genetics. Part C, Seminars in medical genetics
2023

Cell type characterization of spatiotemporal gene co-expression modules in Down syndrome brain.

iScience
2023

Late-onset sensory-motor axonal neuropathy, a novel SLC12A6-related phenotype.

Brain : a journal of neurology
2022

A unique presentation of NLRP3-associated autoinflammatory disease: case report.

BMC rheumatology
2022

Genotype and phenotype spectrum of 10 children with STXBP1 gene-related encephalopathy and epilepsy.

Frontiers in pediatrics
2023

A newborn male with Myhre syndrome, hearing loss, and complete syndactyly of fingers 3-4.

Molecular genetics &amp; genomic medicine
2023

Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome.

Mitochondrion
2022

TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions.

American journal of human genetics
2022

The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study.

Epilepsia
2022

Mutation in the STXBP1 Gene Associated with Early Onset West Syndrome: A Case Report and Literature Review.

Pediatric reports
2023

A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity.

Cerebellum (London, England)
2023

A scoping review of post-diagnostic dementia supports for people with intellectual disability.

Aging &amp; mental health

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson's disease.
    BMJ neurology open· 2026· PMID 41877737mais citado
  2. Association of Bassoon (BSN) Gene Mutations With Gait and Motor Impairments in Parkinson's Disease.
    The European journal of neuroscience· 2026· PMID 41802976mais citado
  3. Developmental and Epileptic Encephalopathy due to Cyclin-Dependent Kinase-Like 5 Deficiency: A Single-Center Experience Across Sex Differences.
    Pediatric neurology· 2026· PMID 41619470mais citado
  4. Bardet-Biedl syndrome presenting with early-onset infantile obesity.
    BMJ case reports· 2026· PMID 41611321mais citado
  5. Phenotypic expansion of CALM1/2-associated disorders to include neurologic phenotypes without arrhythmia.
    Human molecular genetics· 2026· PMID 41467504mais citado
  6. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy.
    Orphanet J Rare Dis· 2022· PMID 35189948recente
  7. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review.
    Orphanet J Rare Dis· 2021· PMID 34174912recente
  8. Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls.
    Orphanet J Rare Dis· 2019· PMID 31665043recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2379(Orphanet)
  2. OMIM OMIM:311510(OMIM)
  3. MONDO:0010709(MONDO)
  4. GARD:3203(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q55782601(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual
Compêndio · Raras BR

Síndrome de parkinsonismo de início precoce-perturbação do desenvolvimento intelectual

ORPHA:2379 · MONDO:0010709
Prevalência
<1 / 1 000 000
Casos
2 casos conhecidos
Herança
X-linked recessive
CID-10
G20 · Doença de Parkinson
CID-11
Início
Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0796195
Repurposing
2 candidatos
procyclidineacetylcholine receptor antagonist
trihexyphenidyl
Wikidata
Wikipedia
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades